Skip to content
ClinCalc Pro
Menu
Anthelmintic (praziquinoline)

Praziquantel

Brand names: Cysticide

Praziquantel is an anthelmintic used to treat infections caused by schistosomes (schistosomiasis) and other trematodes and cestodes, including many tapeworm (cestode) infections.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It increases parasite cell membrane permeability to calcium, causing sustained muscular contraction, paralysis and tegumental damage that exposes the worm to host immune attack.

Prescribing in practice

  • It is contraindicated in ocular cysticercosis, and in neurocysticercosis it can provoke harmful inflammatory reactions, so specialist supervision and consideration of corticosteroid cover are required.
  • Concomitant strong hepatic enzyme inducers can markedly lower praziquantel concentrations and reduce efficacy.
  • Tablets are best taken with food and swallowed whole to limit the bitter taste that may cause gagging.

Monitoring

Routine laboratory monitoring is not generally required, but neurological status should be observed when treating central nervous system parasitic disease.

Counselling the patient

  • Take the tablets with food and swallow them whole with water.
  • Drowsiness or dizziness can occur, so take care with driving until you know how it affects you.
  • Report severe headache or neurological symptoms if being treated for an infection involving the brain.

Evidence & guidelines

Praziquantel is the WHO-recommended drug of choice for all forms of schistosomiasis.

Reference: UKHSA; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.